Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Drug-induced Liver Injury Remains Under-reported, Poorly Understood
-
- 10 News Highlights to Mark Gastroparesis Awareness Month
- Akcea, Ionis File NDA for Familial Chylomicronemia Syndrome Drug
- FDA Approves Humira Biosimilar Cyltezo
- FDA Clears truFreeze Cryotherapy Spray for Low-grade Dysplasia in Barrett’s Esophagus
- Drug-Induced Liver Injury Recognition Requires Physician Awareness Nancy S. Reau, MD, FAASLD, AGAF
- AGA Releases Guideline on Therapeutic Drug Monitoring in IBD
- Cap-assisted Colonoscopy Improves Detection of Proximal Colon Adenomas
- Colon Tissue More Permeable to Bacteria in IBS
-
- Exclusive Enteral Nutrition Effective as Steroids for Pediatric Crohn’s
- Fibrosis, not NASH, Predicts Death, Disease in Fatty Liver
- Latiglutenase Improves Symptoms in Certain Patients With Celiac Disease
- Plant-based Diet may be Better Than PPIs for Laryngopharyngeal Reflux
- Smartphone app Could Detect Pancreatic Cancer Using ‘Selfies’
- Adjuvant Imatinib Beneficial for High-risk Gastrointestinal Stromal Tumors
- Controlled Feeding Studies Show Promise for Evaluating Diet-gut Microbiome Interactions
- Microbiome Research Ethics Looking at a ‘Critical Gap’
-
- NIH Features Early Progress in Understanding Microbiome’s Role in IBD
- Pembrolizumab may Become Standard for Advanced Gastric Cancer
- Diet, Lifestyle Play ‘Major Role’ in Colon Cancer Risk
- Gluten-free Diets: In Celiac Disease Absence, a Source of Confusion, Uncertainty
- Patients Require Education About Opioid-induced Constipation